Congenital Deficiency of Alpha-2-Adrenoceptors on Human Platelets : Description of Two Cases

Giacomo Tamponi; Antonella Pannocchia; Carlo Arduino; Mario Bazzan; Nadine Della Dora; Piercarla Schinco; Mauro Buraglio; Mario Eandi

doi:10.1055/s-0038-1646046

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 1987; 58(04): 1012-1016
DOI: 10.1055/s-0038-1646046

Original Article

Schattauer GmbH Stuttgart

Congenital Deficiency of Alpha-2-Adrenoceptors on Human Platelets : Description of Two Cases

Giacomo Tamponi

^*The Cattedra di Ematologia, Istituto di Medicina Interna, University of Torino, Italy

,

Antonella Pannocchia

^*The Cattedra di Ematologia, Istituto di Medicina Interna, University of Torino, Italy

,

Carlo Arduino

The Istituto di Farmacologia e Terapia Sperimentale, University of Torino, Italy

,

Mario Bazzan

^*The Cattedra di Ematologia, Istituto di Medicina Interna, University of Torino, Italy

,

Nadine Della Dora

^*The Cattedra di Ematologia, Istituto di Medicina Interna, University of Torino, Italy

,

Piercarla Schinco

^*The Cattedra di Ematologia, Istituto di Medicina Interna, University of Torino, Italy

,

Mauro Buraglio

The Istituto di Farmacologia e Terapia Sperimentale, University of Torino, Italy

,

Mario Eandi

The Istituto di Farmacologia e Terapia Sperimentale, University of Torino, Italy

› Author Affiliations

Abstract

PDF Download

Summary

The biochemistry and functionality of platelets from two related subjects (mother and son) with alpha-2-adrenoceptor-deficient platelets has been evaluated. Radioligand binding experimentes with the specific alpha-2-adrenergic-receptor antagonist, ³H-yohimbine, showed a drastic reduction of alpha-2-adrenoceptors in platelets from both subjects in comparison with the control values. Electron microscopy studies revealed a normal morphology and a normal number of alpha granules and dense bodies. Levels of adenine nucleotides; 5-hydroxytryptamine; B-thromboglobulin; platelet-factor-4 and thromboxane A₂ production were within normal limits.

Platelet aggregation and 5-hydroxytryplamine production in response to adrenalin (at concentrations up to 50 μM) were absent, whereas ADP, AA, PAF, collagen and thrombin-induced aggregation, secretion, Ca⁺⁺ flux and thromboxane A₂ production were normal.

The inhibitory effect caused by different concentrations of prostacyclin on Ca⁺⁺ flux, aggregation, secretion and thromboxane A₂ production of platelet functionally lacking of alpha-2-adrenoceptor was not distinguishable from control platelets and platelets preincubated with yohimbine.

Keywords

Alpha-2-adrenoceptors - Human platelets - Congenital deficiency

PDF (570 kb)

References

References
1 Kaywin P, McDonaugh H, Insel PA, Shattil SJ. Platelet function in essential thrombocytopenia. New Engl J Med 1978; 229: 505-509
2 Adams T, Shutz D, Goldberg L. Platelet function abnormalities in myeloproliferative disorders. Scand J Haemostas 1974; 13: 215-224
3 Pareti FI, Gugliotta D, Mannucci L, Guarini A, Mannucci PM. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders. Thromb Haemostas 1982; 47: 84-89
4 Garcia-Sevilla JA, Hollingsworth PJ, Smith CB. Alpha-2-adrenoceptors on human platelets: selective labelling by ³H-clonidine and ³H-yohimbine and competitive inhibition by antidepressant drugs. Europ J Pharmac 1981; 74: 329-341
5 Solinger A, Bernstein IL, Glueck HI. The effect of epinephrine on platelet aggregation in normal and atopic subjects. J All Clin Immunol 1973; 51: 29-34
6 Weiss RJ, Smith CB. Altered platelet alpha-2-adrenoceptors in patients with angina pectoris. J Am Coll Cardiol 1983; 2: 631-637
7 Weiss RJ, Tobes M, Wertz CE, Smith CB. Platelet alpha-2-adrenoceptors in chronic congestive heart failure. Am J Cardiol 1983; 52: 101-105
8 Boda Z, Solum NO, Sztaricskai F, Rak K. Study of platelet agglutination induced by the antibiotics of the vancomycin group: Ristocetin, ristomycin, actinoidin and vancomycin. Thromb Haemostas 1979; 42: 1164-1180
9 Born G VR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
10 Rao G HR, White JG, Jachimowicz AA, Witkop CJ. Nucleotide profiles of normal and abnormal platelets by high pressure liquid chromatography. J Lab Clin Med 1974; 84: 839-850
11 Hallam TJ, Sanchez A, Rink TJ. Stimulus response coupling in human platelets changes evoked by platelet activating factor in cytoplasmic free calcium monitored with the fluorescent calcium indicator Quin-2. Biochem J 1984; 218: 819-827
12 Boon NA, Elliott JM, Grahame-Smith DG, Outlaw T, Stump K. Binding of ³H-yohimbine to alpha-2-adrenoceptors on intact human platelets. Brit J Pharmac 1981; 74: 802 P
13 Boon NA, Elliott JM, Grahame-Smith DG, St John-Green T, Stump K. A comparison of alpha-2-adrenoceptor binding characteristic of intact human platelets identified by ³H-yohimbine and ³H-dihydroergocryptine. J Autonom Pharmac 1983; 3: 89-95
14 Arduino C, Bazzan M, Buraglio M, Eandi M, Gennazzani E, Libero L. Alpha-2-adrenoceptors on intact platelets of patients with ischaemic heart disease: correlation with secretory platelet function. Brit J Clin Pharmac 1986; 21: 104-105 P
15 Johnson PC, Ware JA, Cliveden PB, Smith M, Dvorak AM, Salzman EW. Measurement of ionized calcium in blood platelets with the photoprotein aequorin: comparison with quin-2. J Biol Chem 1986; 260: 1069-1076
16 Brodde OE, Anlauf H, Graben N, Bock KD. Age-dependent decrease on alpha-2-adrenergic receptors number in human platelets. Eur J Pharmac 1982; 81: 345-347
17 Hollister AS, Fitzgerald GA, Nadeau J HJ, Roberson D. Acute reduction in human platelet alpha-2-adrenoceptor affinity for agonist by endogenous catecholamines. J Clin Invest 1983; 72: 1498-1505
18 Suiideisan PR, Weintraub M, Hershey LA, Kroening BH, Hasday YD, Bancrjcc SP. Platelet alpha-adrcncrgic receptuii, in obesity, allciulioii with wight loss. Clin Pharmac Ther 1983; 33: 776-785
19 O’Brien JR. Variability in the aggregation of human platelets by adrenalin. Nature 1964; 202: 1188-1190
20 Swart SS, Pearson D, Wood JK, Barne DB. Human platelet alplia-2-adrr.nnrrptnrs- relationship between ladioligand binding Kludier. and adrenalin induced aggregation in normal individuals. Europ J Pharmac 1984; 103: 25-32
21 Scrutton MC, Clare KA, Hutton RA, Bruckdorfer KR. Depressed responsiveness to adrenalin in platelets from apparently normal human donors : a familial trait. Brit J Haemat 1981; 49: 303-314
22 Rao AK, Willis J, Wachtfogel Y, Beckett C. Normal inhibition of PGI₂-stimulated cyclic AMP levels despite impaired platelet aggregation response to epinephrine. Thromb Haemostas 1985; 54: 7 (Abstr)
23 Mdnlyie DE. In: Platelet in Biology and Pathology-2. Gordon JL. (ed), pp 211-247 Elsevier/North Holland Biochemical Press; Amsterdam: 1981
24 Fain JN, Garcia-Sainz JA. Role of phosphatidilinositol turnover in alpha-1 and of adenylate cyclase inhibition in alpha-2 effects of catecholamines. Life Sci 1980; 26: 1183-1194
25 Smith SK, Limbird LE. Evidence that human platelet alpha-adrenergic receptors coupled to inhibition of adenylate cyclase are not associated with the subunit of adenylate cyclase ADP-ribosylated by cholera toxin. J Biol Chem 1982; 257: 10471-10478
26 Zavoico GB, Feinstein MB. Cytoplasmic calcium in platelets is controlled by cyclic AMP; antagonism between stimulators and inhibitors of adenylate cyclase. Biochem Biophys Res Commun 1984; 120: 579-585
27 Pannocchia A, Hardisty RM. Cyclic AMP inhibits platelet activation indipen-dently on its effect on cytosolic free calcium. Biochem Biophys Res Commun 1985; 127: 339-345
28 Bennet JS, Vilaire G. Exposure of platelet fibrinogen receptors by ADP and adrenalin. J Clin Invest 1979; 64: 1393-1401
29 Peerschke E IB. Indication of human fibrinogen receptors by epinephrine in the absence of released ADP. Blood 1982; 60: 71-77
30 Peerschke E IB. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombine. Am J Hematol 1984; 16: 335-345
31 Propping P, Friedl W. Genetic control of adrenergic receptors on human platelets. A twin study. Hum Genet 1983; 64: 105-109